Du vergisst aber das die meissten Bio's viel mehr Aktien haben.Fliesst Kapital rein, ist wes wohl ein Unterschied ob ich 15 Millionen Aktien habe oder 150 Millionen.
Development Status and FDA Approval Process for Macrilen
Date Article§ Oct 26, 2016 Aeterna Zentaris Completes Patient Recruitment for Confirmatory Phase 3 Trial of Macrilen Apr 13, 2015 Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen in AGHD Nov 6, 2014 FDA Issues Complete Response Letter for Macrilen (macimorelin) NDA in Adult Growth Hormone Deficiency Jan 6, 2014 Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA Nov 5, 2013 Aeterna Zentaris Submits New Drug Application to FDA for Macimorelin Acetate (AEZS-130) for Evaluation of AGHD
Study Status: This study is ongoing, but not recruiting participants. Estimated Study Completion Date: December 2016 Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Study Status: This study is ongoing, but not recruiting participants. Estimated Study Completion Date: December 2016 Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
doch tatsächlich noch Leute, die bei Biotechs einen engen Stoploss setzen. Die sind jetzt diese wunderbaren Shares los! Und ich hab mir gerade noch ein Päckchen für 3,609€ gegönnt. Sage Danke!
Thread abonnieren
